Pregnancy and MS-Like Illness: What Treatment Data Show

Credibility

Interest

Share:2 min read

Key Takeaway

A review found no clear pattern of serious pregnancy harm in the few reported cases involving two treatments for MS-like conditions, but the evidence is too limited to show they are safe.

What They Found

This review looked at eculizumab and ravulizumab during pregnancy in two conditions that are different from MS: NMOSD, which can cause MS-like attacks on the nerves, and myasthenia gravis, which causes muscle weakness. These medicines block part of the immune system that can drive attacks in those conditions. Only a small number of pregnancies involving these medicines have been reported in people with either condition. Across those reports, the reviewers found no consistent pattern of serious problems for parents or babies. Reports from other illnesses included more pregnancies, but their results may not apply in the same way to people with nerve or muscle conditions.

Who Should Care and Why

This review is most useful to people with NMOSD or myasthenia gravis who are pregnant or planning a pregnancy, and to their caregivers. NMOSD can look like MS, but it is a different condition, so these findings should not guide decisions about MS treatment. If you have NMOSD and take one of these medicines, ask your specialist about the risks of continuing it and the risks of an attack if you stop. An attack during pregnancy or after birth can seriously affect the parent's health, so the decision is not simply about avoiding medicine. Your specialists can plan care together and discuss ways to lower infection risk, since these medicines block part of the immune system.

Important Considerations

This was a review of existing reports, not a study that followed a large group of pregnant people taking these medicines. Because so few pregnancies were reported for NMOSD and myasthenia gravis, uncommon harms could have been missed. The review offers no evidence that these medicines are safe or effective for treating MS during pregnancy.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Treatment Updates Living with MS Caregivers

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like CNS drugs often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News